A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

US Backs AstraZeneca Vaccine With $1.2 Billion Via Operation Warp Speed


The United States Department of Health and Human Services announced it has secured 300 million doses of an experimental vaccine created by AstraZeneca in partnership with Oxford University as part of Operation Warp Speed. The influx of cash will help push the vaccine’s development forward while also ensuring that Americans will have access to a large number of doses. A phase III clinical trial of the vaccine will be conducted on 30,000 subjects in the US.

Operation Warp Speed is a US program dedicated to furthering the development and application of a COVID-19 vaccine and ensuring access for Americans. Many see a vaccine as the catalyst to getting the world’s economies moving again.  The first doses of the AstraZeneca vaccine may be available as soon as September.

Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy